Soft Tissue Infections Clinical Trial
Official title:
Clinical Trial of the Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water in the Closure of Diabetic Foot Ulcer Syndrome.
At present research has generated controversy regarding the utility of antiseptics in wound
management for diabetic foot ulcers syndrome. However, these studies have been done in
tissues and animal models. This study involves the best presently antiseptic for residual
effect and low toxicity in an approach to eliminate microorganisms promoters formation of
biofilm, contributing to the treatment for accelerated closure the diabetic foot ulcers
syndrome .
So it is necessary to determine if irrigation ulcer diabetic foot syndrome with
chlorhexidine 0.125 % aqueous solution determines the decrease of the surface to a greater
extent than the standard treatment using irrigation with sterile deionized water .
The present study be made performed at the Hospital General Leon.
Population:
People with Diabetes Mellitus state of Guanajuato.
Universe:
People with diabetes mellitus and diabetic foot syndrome Guanajuato state . sample: Will be
evaluated in patients with diabetes mellitus presenting loss of continuity of the skin of
the lower limbs and coming to the clinic wound´s of the León General Hospital . This clinic
provides services to patients in the state of Guanajuato with diabetic foot syndrome,
including them within a multidisciplinary management program .
Calculation of Sample :
72 patients; more eight for lost estimates, 40 patients for each group are required to have
a 80 % chance of detecting , with a significance level of 5%, an increase in the primary
outcome measure of 5% in the control group and 6 % in group experimental .
Alpha: 5 % Power : 80 %
Inclusion Criteria:
Indistinct gender Patients over 18 years with Diabetes Mellitus and submit ulcer from
diabetic foot syndrome not involving tendon , capsule or bone.
With proper state of vascular perfusion.
Exclusion Criteria :
Ulcers in patients with interdigital or difficult to measure the affected surface areas.
Patients not be located at follow-up or wish to stop participating in the study.
Methodology:
Will be invited to participate in the study patients with diabetes mellitus consecutive
presented with ulcers plantar to IA or IB grade classification system ulcers , University of
Texas, in the area of Clinical wound´s of the Hospital General Leon between Abril and
November 2014.
After explaining the study information and check which is understandable , they provide the
sheet to be signed informed consent.
Subsequently selected patients will be given a vascular ultrasound to measure the ankle
brachial index and determine the absence of vascular compromise.
They carry out their medical history with emphasis on analyzing clinical data , including
the characteristics of the ulcer (type of exudate , measured surface area affected , type of
tissue involved in the ulcer to its depth ) and biochemical parameters .
Be weighed and measured at the first visit and not having biochemical data are requested to
collect this information in subsequent follow-up visit .
They were then treated with the principles of the standard treatment, under the following
criteria :
- Remove the ulcer exudate by spraying one of the two ingredients making mechanical drive
for 5 minutes, or until completely negative to the visual evidence of exudate.
- Completely remove hyperkeratosis and devitalized tissue from the periphery of the ulcer
with cutting material dissection with sterile dressing and drag , until visually
eliminate the exudate.
- The treated area is dry and sore
- Two photographs at a distance of 20 cm perpendicular to the ulcer will be taken,
covering a 1 square centimeter reference for measuring the area affected by diabetic
foot ulcer syndrome.
- The solution so blinded to the ulcer and covered with sterile dressing will be applied
for 24 hours .
- The patient will be instructed to continue treatment every 24 hours as follows :
- Sterile dressing will be removed and continuously irrigate for 5 seconds with the
ingredient that was assigned .
- Undiscovered for 24 hours , until the next day irrigation dressing area will be placed
. Also need to avoid contact with any surface over the affected area until the next
assessment .
- Perform the same strategy for 24 hours , and on day 7 will go to the wound clinic to
clinical evaluation.
- Every 7 days until complete 6 views, clinical evaluation are performed, irrigation with
the selected ingredient and it will take 2 pictures at a distance of 20 cm
perpendicular to the boil again , covering a reference of 1 square centimeter to
measure the area affected by the diabetic foot ulcer syndrome.
- Every 7 days of initiation of therapy in the clinic consultation wounds measured and
circulation and comment the following:
- Ulcer area in square millimeters .
- Coloring of the ulcer .
- Type of exudate ; turbid serous .
- Type of tissue involved in the ulcer to its depth. If any patients have increased
intensity of the signs and symptoms of diabetic foot syndrome, classified as a major
step on the scale of ulcers Classification System of the University of Texas, perform
analysis and comprehensive treatment will be redefined according to the suggestions of
ulcer classification system of the University of Texas.
Material cleaning the ulcer :
Ingredient 1: Preparation of spray application of chlorhexidine gluconate 0.125% .
Ingredient 2: Preparation of spray application of sterile deionized water .
Method of application of ingredients as described previously .
Method of randomization : is effected by assigning random numbers balanced computer, the
code will be assigned to each of the ingredients which have identical presentations , they
will balance to the sample size . The code will not be known by the patient, observer and
analyst. Only be known by one of the advisors.
Statistical methods :
The description of the data, in the case of non-numerical variables will be performed by
reporting proportions and confidence interval of 95 % (95 %) in the case of numerical
variables, the description will be made based on averages and standard deviation or medians
and Q1- Q3 range , depending on the result of the Kolmogorov-Smirnov test to evaluate the
Gaussian distribution of the data.
Comparison of numerical variables were not performed by Chi square test . Comparison of the
rates of reduction in the size of ulcers of diabetic foot syndrome for both treatments will
be based on the t test for independent samples or by Kruskal- Wallis test , depending on
data distribution .
In all cases be considered as the significance level alpha value <0.05 .
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04332679 -
Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes
|
N/A | |
Completed |
NCT00187759 -
Placebo Controlled Study of Antibiotic Treatment of Soft Tissue Infection
|
N/A | |
Completed |
NCT01557426 -
Soft Tissue Ultrasound of Infections
|
Phase 1 | |
Active, not recruiting |
NCT04257097 -
Reinforced PTFE Meshes Versus Customized Titanium Meshes
|
N/A | |
Enrolling by invitation |
NCT05826873 -
Discharge Stewardship in Children's Hospitals
|
N/A | |
Completed |
NCT04393909 -
Improving Safety of Diagnosis and Therapy in the Inpatient Setting
|
N/A | |
Active, not recruiting |
NCT02595047 -
Autologous Prefabrication of Body Surface Tissues/ Organs(e.g. Joint)
|
N/A | |
Completed |
NCT01790698 -
Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).
|
||
Completed |
NCT00785200 -
MRSA Colonization and Control in the Dallas County Jail
|
N/A | |
Completed |
NCT00426933 -
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
|
Phase 2 | |
Terminated |
NCT00102947 -
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
|
Phase 4 | |
Completed |
NCT00451386 -
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
|
Phase 2 | |
Completed |
NCT03643952 -
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
|
Phase 2 | |
Recruiting |
NCT02979951 -
Fosfomycin i.v. for Treatment of Severely Infected Patients
|
||
Completed |
NCT02600871 -
Skin and Soft Tissue Infection (SSTI) Study
|
Phase 4 | |
Completed |
NCT00303589 -
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
|
Phase 2 | |
Completed |
NCT04286334 -
Three-dimensional Bone Regeneration Using Custom-made Meshes With and Without Collagen Membrane
|
N/A | |
Recruiting |
NCT05471908 -
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
|
N/A | |
Withdrawn |
NCT03982030 -
Dalbavancin Outpatient Pilot
|
Phase 4 | |
Terminated |
NCT00430937 -
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
|
Phase 3 |